E-LIB Suche - Ergebnisse für: O'Connor, P.W.

1

Reducing clinical trial risk in multiple sclerosis:

De Gasperis-Brigante, C.D. ; Parker, J.L. ; O'Connor, P.W..
Multiple Sclerosis and Related Disorders. 5 (2016) - p. 81-88 , 2016

Link: https://doi.org/10.1016/..

2

Long-term clinical and magnetic resonance imaging outcomes ..:

Jumah, M.A. ; Li, D.B. ; Yamout, B....
Multiple Sclerosis and Related Disorders. 3 (2014) 6 - p. 755-756 , 2014

Link: https://doi.org/10.1016/..

3

Effect of teriflunomide on lymphocyte and neutrophil counts..:

Comi, G. ; Freedman, M.S. ; Kappos, L....
Journal of the Neurological Sciences. 333 (2013) - p. e376 , 2013

Link: https://doi.org/10.1016/..

4

Teriflunomide added to interferon-β in relapsing multiple s..:

Freedman, M.S. ; Wolinsky, J.S. ; Wamil, B....
Neurology. 78 (2012) 23 - p. 1877-1885 , 2012

Link: https://doi.org/10.1212/..

5

Disease activity return during natalizumab treatment interr..:

O'Connor, P.W. ; Goodman, A. ; Kappos, L....
Neurology. 76 (2011) 22 - p. 1858-1865 , 2011

Link: https://doi.org/10.1212/..

6

The efficacy of natalizumab in patients with relapsing mult..:

for the AFFIRM and SENTINEL Investigators ; Hutchinson, M. ; Kappos, L....
Journal of Neurology. 256 (2009) 3 - p. 405-415 , 2009

Link: https://doi.org/10.1007/..

7

FP33-WE-03 Effects of natalizumab treatment on sustained im..:

Munschauer, F. ; Giovannoni, G. ; O'Connor, P.W....
Journal of the Neurological Sciences. 285 (2009) - p. S109 , 2009

Link: https://doi.org/10.1016/..

8

Ethics of placebo-controlled clinical trials in multiple sc..:

Polman, C. H. ; Reingold, S. C. ; Barkhof, F....
Neurology. 70 (2008) 13_part_2 - p. 1134-1140 , 2008

Link: https://doi.org/10.1212/..

9

4-Aminopyridine toxicity with unintentional overdose in fou..:

Burton, J. M. ; Bell, C. M. ; Walker, S. E..
Neurology. , 2008

Link: https://doi.org/10.1212/..

10

Natalizumab reduces visual loss in patients with relapsing ..:

Balcer, L. J. ; Galetta, S. L. ; Calabresi, P. A....
Neurology. 68 (2007) 16 - p. 1299-1304 , 2007

Link: https://doi.org/10.1212/..

11

Neutralizing antibodies to interferon beta: Assessment of t..:

Goodin, D. S. ; Frohman, E. M. ; Hurwitz, B....
Neurology. 68 (2007) 13 - p. 977-984 , 2007

Link: https://doi.org/10.1212/..

12

Voxel-based analysis of the evolution of magnetization tran..:

Chen, J.T. ; Kuhlmann, T. ; Jansen, G.H....
NeuroImage. 36 (2007) 4 - p. 1152-1158 , 2007

Link: https://doi.org/10.1016/..

13

The incidence and significance of anti-natalizumab antibodi..:

Calabresi, P. A. ; Giovannoni, G. ; Confavreux, C....
Neurology. 69 (2007) 14 - p. 1391-1403 , 2007

Link: https://doi.org/10.1212/..

14

MRI outcomes in a placebo-controlled trial of natalizumab i..:

Miller, D. H. ; Soon, D. ; Fernando, K. T....
Neurology. 68 (2007) 17 - p. 1390-1401 , 2007

Link: https://doi.org/10.1212/..

15

A Phase II study of the safety and efficacy of teriflunomid..:

O'Connor, P. W. ; Li, D. ; Freedman, M. S....
Neurology. 66 (2006) 6 - p. 894-900 , 2006

Link: https://doi.org/10.1212/..